|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.31 CNY | -3.68% |
|
-5.02% | +15.48% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
| Capitalization | 7.48B 1.05B | P/E ratio 2022 |
23.7x | P/E ratio 2023 | 19.4x |
|---|---|---|---|---|---|
| Enterprise value | 6.62B 929M | EV / Sales 2022 |
3.64x | EV / Sales 2023 | 3.41x |
| Free-Float |
72.13% | Yield 2022 |
2.81% | Yield 2023 | 4.22% |
More valuation ratios
* Estimated data
More news
| 1 day | +4.50% | ||
| 1 week | -1.39% | ||
| Current month | -5.54% | ||
| 1 month | -13.30% | ||
| 3 months | -18.34% | ||
| 6 months | +18.66% | ||
| Current year | +19.89% |
1 week
11.95
12.99
1 month
11.9515.26
Current year
8.3617.28
1 year
8.3617.28
3 years
7.2717.28
5 years
4.6417.28
10 years
3.3318.18
| Director | Title | Age | Since |
|---|---|---|---|
Tao Wang
CEO | Chief Executive Officer | 56 | 18-01-15 |
Li Ye
DFI | Director of Finance/CFO | 49 | 22-04-17 |
Yue Hong Shen
BRD | Director/Board Member | 49 | 21-01-24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ping Wang
BRD | Director/Board Member | 49 | 21-01-24 |
You Qiang Yu
CHM | Chairman | 62 | 03-08-26 |
Xue Gen Zheng
BRD | Director/Board Member | 59 | 08-01-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +4.50% | -1.39% | +28.31% | +52.87% | 1.26B | ||
| -0.45% | +2.40% | +4.53% | +49.22% | 4.58B | ||
| -0.79% | -0.66% | -31.50% | -13.65% | 3.53B | ||
| -0.14% | -0.07% | +6.49% | +4.23% | 3B | ||
| -1.89% | -2.70% | -17.75% | -6.51% | 2.61B | ||
| +0.34% | -0.07% | -15.11% | -25.20% | 2.22B | ||
| -0.31% | -3.35% | +46.50% | +111.99% | 1.81B | ||
| -0.10% | -1.45% | -18.28% | -40.24% | 1.42B | ||
| -0.62% | -0.31% | -25.81% | -32.13% | 1.35B | ||
| -0.75% | 0.00% | +10.83% | -15.18% | 1.29B | ||
| Average | -0.02% | -0.99% | -1.18% | +8.54% | 2.31B | |
| Weighted average by Cap. | -0.27% | -1.12% | -3.38% | +11.52% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.81B 254M | 1.94B 273M |
| Net income | 273M 38.35M | 383M 53.8M |
| Net Debt | -920M -129M | -861M -121M |
More financial data
* Estimated data
Employees
2,687
Sector
Pharmaceuticals
Calendar
2024-10-21
- Q3 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-09-09 | 12.31 ¥ | -3.68% | 22,419,680 |
| 24-09-09 | 12.78 ¥ | +4.50% | 35,161,890 |
| 24-09-06 | 12.23 ¥ | -2.94% | 31,847,090 |
| 24-09-05 | 12.60 ¥ | -1.87% | 20,297,570 |
| 24-09-04 | 12.84 ¥ | -0.16% | 18,092,800 |
End-of-day quote Shenzhen S.E., September 08, 2024
More quotesAnnual profits - Rate of surprise
- Stock Market
- Equities
- 300181 Stock